Liquid Biopsy Market Size to Grow US$ 11,759.07 Million by 2027 - PowerPoint PPT Presentation

About This Presentation
Title:

Liquid Biopsy Market Size to Grow US$ 11,759.07 Million by 2027

Description:

The liquid biopsy market size is projected to reach US$ 8,123.85 million by 2027 from US$ 3,861.49 million in 2019. The liquid biopsy market CAGR is estimated to grow at 9.9% from 2020 to 2027. – PowerPoint PPT presentation

Number of Views:2
Date added: 29 September 2022
Slides: 9
Provided by: avi@8899
Tags:

less

Transcript and Presenter's Notes

Title: Liquid Biopsy Market Size to Grow US$ 11,759.07 Million by 2027


1
Liquid Biopsy Market Global Analysis and
Forecast to 2027
  • Published Date Apr 2020

Email sales_at_theinsightpartners.com
2
Report Studies
Email sales_at_theinsightpartners.com
  • Liquid Biopsy Market Forecast to 2027 COVID-19
    Impact and Global Analysis by Product
    Services (Equipment, Reagents Kits, and
    Services), Sample (Blood Based, Urine Based, and
    Other Samples), Circulating Biomarker
    Circulating Tumor Cells (CTC), Exosomes, and
    Free Nucleic Acid, Application Noninvasive
    Prenatal Testing (NIPT), Oncology, Transplant
    Diagnostics, and Other Applications, and End
    User (Academic Research Institutes, Hospitals,
    Reference Laboratories, and Other End Users)

3
Liquid Biopsy Market Overview
Email sales_at_theinsightpartners.com
  • The Liquid Biopsy Market size is projected to
    reach US 8,123.85 million by 2027 from US
    3,861.49 million in 2019. The liquid biopsy
    market CAGR is estimated to grow at 9.9 from
    2020 to 2027.
  • Liquid biopsy is a revolutionary technology that
    is opening up various perspectives. The
    technology consists of isolation and detection of
    circulating tumor cells, tumor DNA and exosomes,
    which provide genomic information about the
    cancer patients. Liquid biopsy is used in cancer
    diagnosis to study the response or resistance to
    given treatments.

4
Key Segment Market
Email sales_at_theinsightpartners.com
  • Segment By Type-
  • By Product Services (Equipment, Reagents
    Kits, and Services)
  • By Sample (Blood Based, Urine Based, and Other
    Samples)
  • By Circulating Biomarker Circulating Tumor Cells
    (CTC), Exosomes, and Free Nucleic Acid
  • By Application Noninvasive Prenatal Testing
    (NIPT), Oncology, Transplant Diagnostics, and
    Other Applications
  • By End User (Academic Research Institutes,
    Hospitals, Reference Laboratories, and Other End
    Users)

Download Sample Here
5
Liquid Biopsy Market Value
Email sales_at_theinsightpartners.com
  • CAGR of 9.9 (2020 to 2027)

6
Company Profiles
Email sales_at_theinsightpartners.com
  • Biocept, Inc
  • Bio-Rad Laboratories Inc
  • LungLife AI, Inc
  • Exosome Diagnostics
  • F. Hoffmann-la Roche ltd
  • Exact Sciences Corporation
  • Inivata Ltd
  • MDxHealth
  • Qiagen
  • Thermo Fisher Scientific Inc.

Download Sample Here
7
By Geography
Email sales_at_theinsightpartners.com
  • North America (the US, Canada, and Mexico)
  • Europe (the UK, Germany, France, Italy, Spain,
    and the Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia,
    South Korea, and the Rest of Asia Pacific)
  • Middle East Africa (the UAE, Saudi Arabia,
    South Africa, and the Rest of Middle East
    Africa)
  • South Central America (Brazil, Argentina, and
    the Rest of South Central America).

8
THANKYOU!
  • Phone  1-646-491-9876
  • E-Mail sales_at_theinsightpartners.com
Write a Comment
User Comments (0)
About PowerShow.com